ethyl pyruvate has been researched along with Colorectal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amoscato, AA; Beer-Stolz, D; Chavez, AR; de Vera, ME; Liang, X; Lotze, MT; Loughran, P; Schapiro, NE; Thorne, SH; Zeh, HJ | 1 |
1 other study(ies) available for ethyl pyruvate and Colorectal Neoplasms
Article | Year |
---|---|
Ethyl pyruvate administration inhibits hepatic tumor growth.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Fluorescent Antibody Technique, Direct; Genes, Reporter; Genetic Vectors; HMGB1 Protein; Injections, Subcutaneous; Interleukin-6; Lentivirus; Liver Neoplasms, Experimental; Luciferases, Renilla; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Pyruvates; Random Allocation; Time Factors; Transduction, Genetic; Transfection; Tumor Burden | 2009 |